Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02899065 · ClinicalTrials.gov registry record · NA
Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 200
- Enrollment target
NCT02899065 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 200 participants.
The verdict
NCT02899065, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
Study Summary
This will be a prospective, patient-oriented, pilot randomized clinical trial to evaluate (in aggregate) both the use of the Roche Cobas Liat Flu/RSV Assay and the use of pharmacist-led education for providers in the interpretation of these test results.
Interventions
- DIAGNOSTIC_TEST Procalcitonin
- OTHER Pharmacist-Led Education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2018-03-06 |
| Est. Completion | 2022-05-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02899065
The ClinicalTrials.gov registry entry for NCT02899065 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Procalcitonin is the first listed.
NCT02899065 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02899065 about?
NCT02899065 is a clinical study titled "Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department". This will be a prospective, patient-oriented, pilot randomized clinical trial to evaluate (in aggregate) both the use of the Roche Cobas Liat Flu/RSV Assay and the use of pharmacist-led education for providers in the interpretation of these test results.
What is the current status of trial NCT02899065?
This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2018-03-06. Estimated completion is 2022-05-20.
What interventions are being tested in trial NCT02899065?
The interventions under investigation include: Procalcitonin (DIAGNOSTIC_TEST), Pharmacist-Led Education (OTHER).
Who is sponsoring clinical trial NCT02899065?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.